Trump will be positive for gold
Following a prolonged period of poor performance, many investors have started to reappraise the prospects for emerging markets (EMs).
Troy Asset Management's Tom Yeowart explains the appeal of multi-asset investing and how a firm's demise worked in his favour.
Reveals details of launch plans
Tough start to year for the sector
Subject to regulatory approval
Now managed by Troy
Analysis from Kepler Partners
Saacke will continue to run Global Growth fund
Valuations at 10-year highs
Threat to market support
FE Trustnet's Joshua Ausden asks whether discount control mechanisms (DCMs) are really all they are cracked up to be.
Sebastian Lyon's £2.6bn Troy Trojan fund has been labelled "the biggest disappointment" in Chelsea Financial's biannual RedZone list of underperforming funds.
Troy Trojan Income manager Francis Brooke has been reducing his fund's position in utilities to protect against the threat of rising bond yields.
Troy Asset Management is to take over from Taube Hodson Stonex (THX) as manager of the Electric & General global equity fund.
Investment trusts you can trust?
Troy Asset Management's Hugo Ure has been promoted to co-manager of the Income & Growth investment trust run by Francis Brooke.
Troy Asset Management has renamed its Trojan Capital fund to reflect the portfolio's increasingly global remit.
The continued intervention of central banks in financial markets has stopped them from functioning in the normal manner, according to Troy's Sebastian Lyon.
Troy Trojan Capital
Troy Trojan fund manager Sebastian Lyon has said equity market dynamics in 2014 are comparable to those seen ahead of the financial crisis in 2007.
Tom Yeowart has joined Troy Asset Management to run the Troy Spectrum fund, working under chief executive Sebastian Lyon and fund manager Francis Brooke.
Sebastian Lyon, manager of the Troy Trojan fund, has warned investors are becoming more complacent than they have been at any point since the financial crisis erupted, leaving them vulnerable to a shock event.
Troy Asset Management's Francis Brooke has said the proposed takeover of AstraZeneca will go ahead once Pfizer eases politicians' concerns on the future of the UK's research industry.